Journals

</th></tr>

Bevantolol

240px
Systematic (IUPAC) name
(RS)-[2-(3,4-dimethoxyphenyl)ethyl][2-hydroxy-3-(3-methylphenoxy)propyl]amine
Clinical data
AHFS/Drugs.com	International Drug Names
Legal status	℞ (Prescription only)
Routes of administration	Oral
Identifiers
CAS Registry Number	59170-23-9 7pxY
ATC code	C07AB06
PubChem	CID 2372
DrugBank	DB01295 7pxY
ChemSpider	2282 7pxY
UNII	34ZXW6ZV21 7pxY
ChEBI	CHEBI:238698 7pxY
ChEMBL	CHEMBL314010 7pxY
Chemical data
Formula	C20H27NO4
Molecular mass	345.43 g/mol
SMILES O(c1ccc(cc1OC)CCNCC(O)COc2cc(ccc2)C)C
InChI InChI=1S/C20H27NO4/c1-15-5-4-6-18(11-15)25-14-17(22)13-21-10-9-16-7-8-19(23-2)20(12-16)24-3/h4-8,11-12,17,21-22H,9-10,13-14H2,1-3H3  7pxY Key:HXLAFSUPPDYFEO-UHFFFAOYSA-N  7pxY
14pxY (what is this?)  (verify)

Bevantolol (INN) is a drug that acts as both a beta blocker and a calcium channel blocker.